# US 2026/0109973 A1 · High-throughput combinatorial genetic modification system and optimized cas9 enzyme variants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0109973 A1
- Document ID: US20260109973A1
- Status: Published application
- Kind: A1
- Application number: 19/305,828
- Filed: 2025-08-21
- Published: 2026-04-23
- Earliest claimed: 2018-09-19
- Assignees: The University of Hong Kong
- Applicants: The University of Hong Kong
- Inventors: Alan Siu Lun Wong; Gigi Ching Gee Choi
- Web page: https://patentgrep.com/patent/US20260109973A1

## CPC

- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 15/1082: {Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/102: {Mutagenizing nucleic acids}
- C12N 15/1031: {mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR}
- C12N 15/1058: {Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms}
- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 15/66: General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- C40B 40/08: Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
- C40B 50/06: Biochemical methods, e.g. using enzymes or whole viable microorganisms
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C40B 20/04: Identifying library members by means of a tag, label, or other readable or detectable entity associated with the library members, e.g. decoding processes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present invention provides to an improved high-throughput system and method for generated and screening of genetic variants by combinatorial modifications. Also provided are optimized SpCas9 enzyme variants produced by this system.

## Claims

### Claim 1

A method for generating a combinatorial genetic construct, comprising:
(a) cleaving a first DNA vector with the first type IIS restriction enzyme to release a first DNA fragment comprising a first DNA segment, the first and second recognition sites for a second type IIS restriction enzyme, and the first barcode flanked by a first and a second ends generated by the first type IIS restriction enzyme, wherein the first DNA vector comprises from 5′ to 3′:
a first recognition site for a first type IIS restriction enzyme,
a DNA element,
a first and a second recognition sites for a second type IIS restriction enzyme,
a barcode uniquely assigned to the DNA element, and
a second recognition site for the first type IIS restriction enzyme;
(b) cleaving an initial expression vector comprising a promoter with the second type IIS restriction enzyme to linearize the initial expression vector near 3′ end of the promoter and generate two ends that are compatible with the first and second ends of DNA fragment of (a);
(c) annealing and ligating the first DNA fragment of (a) into the linearized expression vector of (b) to form a 1-way composite expression vector in which the first DNA fragment and the first barcode are operably linked to the promoter at its 3′ end;
(d) cleaving a second DNA vector with the first type IIS restriction enzyme to release a second DNA fragment comprising the second DNA segment, the first and second recognition sites for the second type IIS restriction enzyme, and the second barcode flanked by a first and a second ends generated by the first type IIS restriction enzyme, wherein the second DNA vector comprises from 5′ to 3′:
a first recognition site for a first type IIS restriction enzyme,
a DNA element,
a first and a second recognition sites for a second type IIS restriction enzyme,
a barcode uniquely assigned to the DNA element, and
a second recognition site for the first type IIS restriction enzyme;
(e) cleaving the composite expression vector of (c) with the second type IIS restriction enzyme to linearize the composite expression vector between the first DNA element and the first barcode and generate two ends that are compatible with the first and second ends of DNA fragment of (d);
(f) annealing and ligating the second DNA fragment of (d) into linearized composite expression vector of (e) between the first DNA element and the first barcode to form a 2-way composite expression vector in which the first DNA fragment, the second DNA fragment, the second barcode, and the first barcode are operably linked in this order to the promoter at its 3′ end,
wherein the first and second DNA elements encode the first and second segments of a pre-selected protein from its N-terminus that are immediately adjacent to each other, and wherein the first and second DNA fragments are joined to each other in the 2-way composite expression vector without any extraneous nucleotide sequence resulting in any amino acid residue not found in the pre-selected protein, and wherein each of the first and second DNA elements comprises one or more mutations.

### Claim 2 (depends on 1)

The method of claim 1, wherein steps (d) to (f) are repeated until the nth time to incorporate the nth DNA fragment comprising the nth DNA element, the first and second recognition sites for the second type IIS restriction enzyme, and the nth barcode into an n-way composite expression vector, the nth DNA elment encoding for the nth or the second to the last segment of the pre-selected protein from its C-terminus, further comprising the steps of:
(x) providing a final DNA vector, which comprises between a first and a second recognition sites for a first type IIS restriction enzyme, a (n+1)th DNA element, a primer-binding site, and a (n+1)th barcode;
(y) cleaving the final DNA vector with the first type IIS restriction enzyme to release a final DNA fragment comprising from 5′ to 3′: the (n+1)th DNA element, the primer-binding site, and the (n+1)th barcode, flanked by a first and a second ends generated by the first type IIS restriction enzyme;
(z) annealing and ligating the final DNA fragment into the n-way composite expression vector, which is produced after steps (d) to (f) are repeated for the nth time and has been linearized by the second type IIS restriction enzyme, to form a final composite expression vector,
wherein the first, second, and so on up to the nth and the (n+1)th DNA elements encode the first, second, and so on up to the nth and the last segments of the pre-selected protein from its N-terminus that are immediately adjacent to each other, and wherein the first, second, and so on up to the nth and the last DNA fragments are joined to each other in the final composite expression vector without any extraneous nucleotide sequence resulting in any amino acid residue not found in the pre-selected protein, and wherein each of the DNA elements comprises one or more mutations.

### Claim 3 (depends on 1)

The method of claim 1, wherein the first type IIS restriction enzyme and the second type IIS restriction enzyme generate compatible ends upon cleaving a DNA molecule.

### Claim 4 (depends on 1)

The method of claim 1, wherein the first type IIS restriction enzyme is BsaI and the second type IIS restriction enzyme is BbsI.

### Claim 5 (depends on 2)

The method of claim 2, wherein the first type IIS restriction enzyme and the second type IIS restriction enzyme generate compatible ends upon cleaving a DNA molecule.

### Claim 6 (depends on 2)

The method of claim 2, wherein the first type IIS restriction enzyme is BsaI and the second type IIS restriction enzyme is BbsI
